Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSIMERTINIB vs OXAPROZIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSIMERTINIB vs OXAPROZIN: Safety Overview

Metric OSIMERTINIB OXAPROZIN
Total FAERS Reports 27,750 439
Deaths Reported 12,456 4
Death Rate 44.9% 0.9%
Hospitalizations 5,277 23
Average Patient Age 68.2 yrs 62.9 yrs
% Female Patients 66.0% 83.8%
FDA Approval Date Nov 13, 2015 Apr 12, 2001
Manufacturer AstraZeneca Pharmaceuticals LP Dr. Reddy's Laboratories Limited
Route ORAL ORAL
Marketing Status Prescription Prescription